Publicacions en què col·labora amb PILAR MUÑOZ FERNÁNDEZ (17)

2023

  1. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

2022

  1. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

    Frontiers in Immunology, Vol. 13

  2. Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))

    Molecular Therapy - Oncolytics

  3. Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  4. Physiological lentiviral vectors for the generation of improved CAR-T cells

    Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349

2020

  1. GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels

    Stem Cells Translational Medicine, Vol. 9, Núm. 5, pp. 636-650

  2. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

  3. WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation

    Molecular Therapy - Methods and Clinical Development, Vol. 19, pp. 220-235

2016

  1. Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model

    Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353

  2. Lent-On-Plus Lentiviral vectors for conditional expression in human stem cells

    Scientific Reports, Vol. 6

2015

  1. Mesenchymal stromal cells express GARP/LRRC32 on their surface: Effects on their biology and immunomodulatory capacity

    Stem Cells, Vol. 33, Núm. 1, pp. 183-195

2014

  1. A chimeric HS4-SAR insulator (IS2) that prevents silencing and enhances expression of lentiviral vectors in pluripotent stem cells

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis

    Cell Transplantation, Vol. 22, Núm. 5, pp. 839-854

  2. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: A human cellular model for Wiskott-Aldrich syndrome

    DMM Disease Models and Mechanisms, Vol. 6, Núm. 2, pp. 544-554

2012

  1. Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors

    PLoS ONE, Vol. 7, Núm. 6

2011

  1. Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-on cell lines

    PLoS ONE, Vol. 6, Núm. 8

2009

  1. Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors

    Human Gene Therapy, Vol. 20, Núm. 11, pp. 1279-1290